Need all Congresses? Press Enter for expanded federal results.

HB 1099

South Dakota House of Representatives bill in Session 71.

Status: enacted. Latest action: March 10, 2026.

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Bill ID SD-71-HB-1099
Session 71
Status enacted
Committee Senate Health and Human Services
House of Representatives enacted 2026-03-10
Summary

An Act to reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Sponsor
Pischke, Tom
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-20 Introduced Bill introduced
2026-03-10 Status enacted
2026-03-10 Latest Action Signed by the Governor
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States